Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioblastoma | 6 | 2023 | 1797 | 0.810 |
Why?
|
| Medulloblastoma | 3 | 2014 | 540 | 0.700 |
Why?
|
| Brain Neoplasms | 9 | 2023 | 4849 | 0.700 |
Why?
|
| Cerebellar Neoplasms | 2 | 2014 | 434 | 0.680 |
Why?
|
| Germinoma | 2 | 2016 | 84 | 0.610 |
Why?
|
| Neoplasms, Experimental | 1 | 2021 | 750 | 0.610 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2020 | 324 | 0.550 |
Why?
|
| Antigens, CD1d | 1 | 2014 | 32 | 0.500 |
Why?
|
| Natural Killer T-Cells | 1 | 2014 | 124 | 0.440 |
Why?
|
| Gastrointestinal Tract | 1 | 2014 | 324 | 0.390 |
Why?
|
| Hedgehog Proteins | 1 | 2013 | 424 | 0.370 |
Why?
|
| Gastrointestinal Diseases | 1 | 2014 | 589 | 0.340 |
Why?
|
| Genomics | 1 | 2019 | 2738 | 0.320 |
Why?
|
| Macrophages | 1 | 2014 | 1304 | 0.310 |
Why?
|
| Neoplastic Stem Cells | 2 | 2016 | 1443 | 0.300 |
Why?
|
| Alnus | 1 | 2022 | 1 | 0.220 |
Why?
|
| Lignans | 1 | 2022 | 15 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 7702 | 0.220 |
Why?
|
| Biguanides | 1 | 2021 | 12 | 0.210 |
Why?
|
| Symporters | 1 | 2022 | 98 | 0.210 |
Why?
|
| Singapore | 2 | 2020 | 31 | 0.210 |
Why?
|
| Brain | 2 | 2016 | 4113 | 0.200 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 14289 | 0.200 |
Why?
|
| Oncolytic Viruses | 1 | 2023 | 204 | 0.190 |
Why?
|
| Rhabdoid Tumor | 1 | 2021 | 110 | 0.190 |
Why?
|
| Ependymoma | 1 | 2022 | 242 | 0.180 |
Why?
|
| Oncolytic Virotherapy | 1 | 2023 | 280 | 0.180 |
Why?
|
| Apgar Score | 1 | 2020 | 55 | 0.180 |
Why?
|
| Infant | 6 | 2016 | 13310 | 0.180 |
Why?
|
| Stillbirth | 1 | 2020 | 82 | 0.180 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 566 | 0.170 |
Why?
|
| Abortion, Induced | 1 | 2020 | 91 | 0.170 |
Why?
|
| Carbon Dioxide | 1 | 2020 | 313 | 0.170 |
Why?
|
| Pneumothorax | 1 | 2020 | 153 | 0.160 |
Why?
|
| Child, Preschool | 5 | 2014 | 16273 | 0.160 |
Why?
|
| China | 1 | 2019 | 606 | 0.150 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 598 | 0.150 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 1519 | 0.150 |
Why?
|
| Databases, Genetic | 1 | 2019 | 745 | 0.130 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 590 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2020 | 37905 | 0.130 |
Why?
|
| Patient Readmission | 1 | 2020 | 548 | 0.130 |
Why?
|
| Energy Metabolism | 1 | 2021 | 992 | 0.130 |
Why?
|
| Mice | 7 | 2023 | 34495 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2023 | 3821 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 677 | 0.130 |
Why?
|
| Photomicrography | 1 | 2014 | 26 | 0.130 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 5159 | 0.130 |
Why?
|
| Pineal Gland | 1 | 2014 | 50 | 0.120 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2014 | 88 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 479 | 0.120 |
Why?
|
| Male | 9 | 2020 | 123000 | 0.120 |
Why?
|
| Animals | 8 | 2023 | 59536 | 0.110 |
Why?
|
| Female | 9 | 2020 | 141928 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 1165 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2023 | 1869 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 328 | 0.100 |
Why?
|
| Humans | 15 | 2023 | 261506 | 0.100 |
Why?
|
| Prognosis | 3 | 2020 | 21713 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1217 | 0.090 |
Why?
|
| Survival Analysis | 3 | 2020 | 9180 | 0.090 |
Why?
|
| Child | 6 | 2022 | 29154 | 0.090 |
Why?
|
| Biomarkers, Tumor | 3 | 2019 | 10331 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 509 | 0.090 |
Why?
|
| Radiography | 1 | 2013 | 1904 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 2508 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2021 | 2947 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 3639 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2022 | 8873 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8223 | 0.070 |
Why?
|
| Pregnancy | 1 | 2020 | 7573 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2023 | 14551 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2020 | 5542 | 0.060 |
Why?
|
| RNA, Messenger | 1 | 2014 | 6150 | 0.060 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2022 | 113 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2020 | 4 | 0.050 |
Why?
|
| Dissection | 1 | 2021 | 156 | 0.050 |
Why?
|
| Serial Passage | 1 | 2020 | 15 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2023 | 905 | 0.050 |
Why?
|
| Patient-Specific Modeling | 1 | 2020 | 28 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2021 | 571 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2014 | 12873 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 7222 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 14889 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2022 | 7226 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 13658 | 0.040 |
Why?
|
| beta Catenin | 1 | 2022 | 688 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 7551 | 0.040 |
Why?
|
| Adolescent | 3 | 2016 | 31252 | 0.040 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2020 | 480 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2022 | 1026 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 1399 | 0.030 |
Why?
|
| Recurrence | 1 | 2022 | 4758 | 0.030 |
Why?
|
| Heterografts | 1 | 2016 | 733 | 0.030 |
Why?
|
| Aged | 1 | 2019 | 70117 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 5395 | 0.030 |
Why?
|
| Adult | 1 | 2019 | 77950 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2022 | 2669 | 0.030 |
Why?
|
| Middle Aged | 1 | 2019 | 86204 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 2483 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 5112 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 7548 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 10035 | 0.010 |
Why?
|
| Disease Management | 1 | 2007 | 1052 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 15179 | 0.010 |
Why?
|
| Registries | 1 | 2007 | 2170 | 0.010 |
Why?
|
| Survival Rate | 1 | 2007 | 12221 | 0.010 |
Why?
|